Patents by Inventor Thomas Petzinger

Thomas Petzinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS IN RESPONDERS
    Publication number: 20180271840
    Abstract: A method for treating amyotrophic lateral sclerosis (ALS) in a subject in need thereof comprising administering to said subject an effective amount of (6R)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole or pharmaceutically acceptable salt thereof, wherein said subject is a treatment responder. In certain embodiments, said subject is a subject with definite amyotrophic lateral sclerosis, a subject with amyotrophic lateral sclerosis symptom onset duration of less than about 18 months, a subject with a high level of serum creatinine, a subject with concomitant riluzole administration and combinations thereof.
    Type: Application
    Filed: March 20, 2018
    Publication date: September 27, 2018
    Inventors: Michael E. BOZIK, Thomas PETZINGER, James L. MATHER, Donald ARCHIBALD
  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS
    Publication number: 20180271839
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 27, 2018
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Wildon FARWELL, Thomas PETZINGER, Steven DWORETZKY
  • COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS
    Publication number: 20160158205
    Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
    Type: Application
    Filed: July 11, 2014
    Publication date: June 9, 2016
    Inventors: Michael E. BOZIK, Gregory HEBRANK, Thomas PETZINGER, Steven DWORETZKY, Wildon FARWELL
  • COMPOSITIONS OF R(+) AND S(-) PRAMIPEXOLE AND METHODS OF USING THE SAME
    Publication number: 20130230569
    Abstract: Compositions of predetermined amounts of R(+) pramipexole and S(?) pramipexole and methods of using the same, including for the treatment and prevention of Parkinson's disease, are provided.
    Type: Application
    Filed: April 12, 2013
    Publication date: September 5, 2013
    Applicant: KNOPP NEUROSCIENCES, INC.
    Inventors: Michael E. BOZIK, Thomas PETZINGER, Valentin GRIBKOFF
  • Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same
    Publication number: 20080014259
    Abstract: Compositions of predetermined amounts of R(+) pramipexole and S(?) pramipexole and methods of using the same, including for the treatment and prevention of Parkinson's disease, are provided.
    Type: Application
    Filed: May 16, 2007
    Publication date: January 17, 2008
    Applicant: KNOPP NEUROSCIENCES, INC.
    Inventors: Michael Bozik, Thomas Petzinger, Valentin Gribkoff
  • COMPOSITIONS AND METHODS OF USING R(+) PRAMIPEXOLE
    Publication number: 20070259930
    Abstract: Pharmaceutical compositions of R(+) pramipexole and methods of using such compositions for the treatment or prevention of diseases associated with or related to mitochondrial dysfunction or increased oxidative stress are disclosed.
    Type: Application
    Filed: April 10, 2007
    Publication date: November 8, 2007
    Applicant: KNOPP NEUROSCIENCES, INC.
    Inventors: Michael Bozik, Gregory Hebrank, Thomas Petzinger